The Role of Neurotropic B Vitamins in Nerve Regeneration

Baltrusch, Simone

doi:https://doi.org/10.1155/2021/9968228

BioMed Research International

On this page

Abstract Introduction Results and Discussion Conclusion Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Review Article | Open Access

Volume 2021 | Article ID 9968228 | https://doi.org/10.1155/2021/9968228

The Role of Neurotropic B Vitamins in Nerve Regeneration

Simone Baltrusch¹

Academic Editor: Dong-Yuan Cao

Received10 Mar 2021

Accepted05 Jul 2021

Published14 Jul 2021

Abstract

Damage and regeneration naturally occur in the peripheral nervous system. The neurotropic B vitamins thiamine (B1), pyridoxine (B6), and cobalamin (B12) are key players, which maintain the neuronal viability in different ways. Firstly, they constantly protect nerves against damaging environmental influences. While vitamin B1 acts as a site-directed antioxidant, vitamin B6 balances nerve metabolism, and vitamin B12 maintains myelin sheaths. However, nerve injury occurs at times, because of an imbalance between protective factors and accumulating stress and noxae. This will result in the so-called Wallerian degeneration process. The presence of vitamins B1, B6, and B12 paves the way out to the following important regeneration by supporting the development of new cell structures. Furthermore, vitamin B1 facilitates the usage of carbohydrates for energy production, whereas vitamin B12 promotes nerve cell survival and remyelination. Absence of these vitamins will favor permanent nerve degeneration and pain, eventually leading to peripheral neuropathy.

1. Introduction

Damage and regeneration naturally occur in the peripheral nervous system. If the balance of these two processes is disturbed, for example, by chronic diseases such as diabetes, and nerve regeneration is impaired, nerve damage can lead to peripheral neuropathy [1]. Nerve damage can have a single cause (e.g., traumatic compression as a result of acute crush injury or laceration as a result of transection injury), but in many cases (and almost always in the chronic course), it is a combination of reasons, such as laceration, traction, vibration, compression, ischemia, inflammation, alcoholism, metabolic (diabetes) or toxic noxae (chemotherapy), surgery, genetic causes, and deficiency in neurotropic B vitamins [1–6]. However, nerves are amazingly regenerative, and regeneration is even possible until approximately 50% of the fibers within a nerve (considered the “point of no return”) are damaged [1]. When a peripheral nerve is centrally injured, the surrounding nonnerve cells initiate the so-called Wallerian degeneration (Figure 1). In this process, the degradation of axon parts (fragmentation) is regarded as a key event that already occurs within one to a few days after the injury. Subsequently, at the site of injury, macrophages are recruited to carry away myelin and dead cells, and the distal stump degenerates. Furthermore, the nonnerve cell responses promote an environment that supports the regeneration of axons over the following months [7, 8]. It has been suggested that certain B vitamins support this nerve regeneration process (Figure 1). In particular, the vitamins B1 (thiamine), B6 (pyridoxine), and B12 (cobalamin) are mentioned in this context. Those are also called “neurotropic” vitamins because of their important functions in the nervous system [9]. Although it is not fully understood how they support the process, numerous animal studies provided evidence for the effect at the histological or molecular level in recent decades. Due to demographic trends, neurodegenerative diseases such as peripheral neuropathy are becoming increasingly important [10] and so will possible treatments.

This is clearly illustrated by diabetes mellitus, which according to the International Diabetes Federation currently affects 463 million people worldwide. Neuropathy is one of the most frequent late complications of this disease [11, 12]. The degeneration process of the nerves does not start with manifestation of diabetes mellitus, but already with impaired glucose tolerance [13]. By the time clinical symptoms of diabetic neuropathy appear, significant and irreversible nerve loss has often already occurred (Figure 1, “point of no return”) [11–13]. It can be speculated that by the time a reduction in nerve conduction velocity of myelinated Aδ nerve fibers is diagnosed, neuropathy has already existed progressively for years, and treatment comes too late. In contrast, the diagnostic method of confocal microscopy of the eye’s cornea, which has been increasingly used in recent years, allows noninvasive detection of changes in the thin C nerve fibers [14–18]. Until now, peripheral nerve fiber density could only be detected invasively by skin punch and subsequent immunofluorescence staining [19]. Independent studies have shown that the loss of skin innervation in diabetic polyneuropathy is preceded by a significant reduction in the nerves of the subepithelial plexus of the cornea [20, 21]. Thus, therapeutic concepts must also be readdressed from the perspective of improved diagnostics. The authors from a double-blind, randomized, controlled study concluded that neurotropic B vitamins represent a starting point in the treatment of diabetic polyneuropathy [22]. In addition to a benefit in the patients’ subjective paresthesias, an improvement was also observed in objectively assessable parameters, such as a decrease in the vibration perception threshold at the second metacarpal and metatarsal bones and an increase in conduction velocity in the peroneal nerve [22]. Other human studies [23–27] and animal experiments [28–30] confirmed the benefit of continuous administration of vitamins B1, B6, and B12 with respect to diabetic neuropathy.

However, to date, there is no recent review article available focusing explicitly on the nerve-regenerating function of B vitamins. Therefore, systematic literature searches were performed to compile the actual evidence from animal studies, provide a current update on this topic for the individual vitamins B1, B6 ,and B12 as well as their combination, and try to derive biochemical explanations.

2. Strategy of Literature Search

First, systematic literature searches in PubMed (https://www.ncbi.nlm.nih.gov/pubmed) for articles that had been published through June 2020 using search term combinations of “vitamin B,” “thiamine,” “pyridoxine,” or “cobalamin” with “nerve regeneration” were conducted. Due to the low number of search results and because it was also aimed to include foreign-language articles, no filters for language, periods, etc. were used. These searches added up to only 101 results of which the majority dealt with vitamin B12. To receive additional evidence on vitamins B1 and B6 by further PubMed searches, search term combinations of “thiamine OR vitamin B1[Title/Abstract]” or “pyridoxine OR vitamin B6[Title/Abstract]” with “nerve role OR nerve function” (filter: “other animals”) were applied. With the 318 additional results, a total of 419 results (including duplicates) from PubMed were observed, of which 383 results remained after removing duplicates. Six additional relevant articles from manual searches in Google Scholar and Google were added. Thereafter, abstracts or, in uncertain cases, full texts were screened. Finally, a total of 26 relevant original articles in the field of experimental animal research were included (Table 1). The exclusion criteria included lack of relevance, redundancy (e.g., secondary publication), human studies, and reviews. However, human studies and reviews (very few relevant articles) in certain cases were used for a more comprehensive overview. Two of the listed full text articles also had to be translated into English because the original articles were published in Russian and Japanese.

3. Results and Discussion

As shown in Table 1, several animal studies provide evidence for a role of neurotropic B vitamins (B1, B6, and B12) in the process of nerve regeneration. Despite extended searches for vitamins B1 and B6, most evidence is still related to vitamin B12. Even for the combination of vitamins B1, B6, and B12, comparatively fewer studies were available.

3.1. Vitamin B1

Vitamin B1 (thiamine) plays a key role as a coenzyme in the carbohydrate metabolism, which is the main energy supply for nerve fibers. Thiamine pyrophosphate is essential for feeding pyruvate to the oxidative energy metabolism, eventually resulting in adenosine triphosphate (ATP) production [29, 31]. In addition, several studies suggest that it acts as a site-directed antioxidant, thereby protecting nerves from oxidative damage [32].

Two animal studies on vitamin B1 about nerve regeneration were identified. One of them showed a regeneration-related effect but both showed neuroprotection (Table 1). Stracke et al. were able to show that vitamin B1 protected peripheral nerves against damage induced by hyperglycemia in living rats, particularly when given early in the course of diabetes. Precisely, they revealed that nerve conduction velocity increased substantially in vitamin B1-treated diabetic rats after three months administration compared with untreated diabetic controls, which was attributed to reduced formation of advanced glycation end-products (AGEs) [29]. Moreover, Song et al. found that vitamin B1 positively influenced nerve excitability of rat neurons after chronic compression of dorsal roots, i.e., it led to improved signal transmission and at the same time reduced hyperexcitability [33], indicating a regenerative effect. These results are supported by an in vitro study from Geng et al., demonstrating that vitamin B1 promoted survival of cultured rat brain neurons in high-density cell culture [34].

Furthermore, a small study from 1976 on patients suffering from the thiamine deficiency disease beriberi provided histological evidence for a regenerative effect of thiamine. Because of Schwann cell clusters with regenerated axons (some even remyelinated), the authors concluded that vitamin B1 stimulated the regeneration of axonal or Wallerian degeneration that takes place in beriberi [35].

Altogether, vitamin B1 (thiamine) plays a pivotal role in the process of nerve regeneration: in nerve cells, it facilitates the usage of carbohydrates for energy production and protects them against oxidative stress, resulting in normalized pain sensation and reduced hyperexcitability.

3.2. Vitamin B6

Vitamin B6 (pyridoxine) is essential for the amino acid metabolism. Hence, vitamin B6 assures the metabolism of neurotransmitters (e.g., GABA and serotonin), which are indispensable for signal transmission in the nervous system, and is associated with the glutamate release. Vitamin B6 may inhibit glutamate release by suppressing presynaptic voltage-dependent Ca2+ entry and protein kinase C activity [36]. In addition, vitamin B6 can—by increasing GABA synthesis—balance the activity of excitatory glutamatergic neurons [37]. It is also needed for the synthesis of sphingolipids—essential constituents of the nerve-surrounding myelin sheath [38].

The one relevant animal study for vitamin B6 rather demonstrates neuroprotection than nerve regeneration (Table 1). In a rat model, vitamin B6 counteracted the nerve-damaging effect of excessive glutamate release, which is an important mechanism of neuronal damage in certain neurological diseases [36]. Clinical evidence on a regenerative function, however, can be derived from a human study in patients with carpal tunnel syndrome (compression injury), in which vitamin B6 treatment increased the conduction velocity of sensory nerves and thus reduced clinical symptoms [39]. Experiments in monkeys showed that vitamin B6 prevented neuronal death in the retina after whole brain ischemic damage from death [40]. However, because of the general function of vitamin B6 in metabolism, highlighting a specific role in nerve regeneration remains difficult.

In conclusion, vitamin B6 (pyridoxine) plays a key role in neurotransmitter synthesis, inhibits the release of neurotoxic glutamate, and restores of sensory nerve function.

3.3. Vitamin B12

As mentioned previously, the evidence for a nerve-regenerating function of vitamin B12 (cobalamin) is strong, and 15 experimental animal studies are available (Table 1). For instance, experiments in rats revealed that it promoted myelin formation and reduced Wallerian degeneration responses [41, 42] and were, similar to vitamin B1 and B6, also believed to have a neuroprotective effect [42] (Figure 1). Cobalamin is essential for the folate dependent methionine cycle. If the amount of B12 does not cover the demand (which is significantly increased during nerve regeneration and myelin formation), not only can important proteins (e.g. the myelin basic protein) not be generated but also homocysteine accumulates and promotes oxidative stress and damage [41–45]. This may aggravate Wallerian degeneration and delay or even prevent the progress of regeneration. While the important role of vitamin B12 in axon regeneration because of microtubule stabilization has been only shown in several diseases of the central nervous system (CNS), another effect, namely, the endoplasmic reticulum (ER) stress level is also probably decisive for the peripheral nervous system (PNS) [43–45]. Especially in the case of a nerve injury concomitant with inflammation, ER stress increases and exceeds self-protective levels, resulting in neuronal death [43–45].

Using vitamin B12 for nerve regeneration in mice after sciatic nerve injury, Yuan et al. demonstrated that it did not only significantly promote functional recovery but also increased the number of myelinated fibers, the diameters of myelinated fibers and axons, and the lamellae number [46]. Similar results have been obtained by Gan et al. who proved a dose-dependent increase of myelin thickness in mice. After the left sciatic nerve of the mice was surgically cut, the animals were subcutaneously treated with vitamin B12 in phosphate-buffered saline (PBS) or only PBS for 12 weeks [47]. In this study, the myelin sheath in regenerated myelinated nerve fibers was significantly thicker in high-dose vitamin B12-treated animals than in the placebo/saline group [47].

Besides effects on myelination, there is cumulating evidence for nerve recovery. Improved nerve terminal and axonal regeneration [48, 49] and increased nerve fiber density [50, 51] were reported. The therapeutic effect of vitamin B12 involves the upregulation of multiple neurotropic factors [47, 52], namely, nerve growth factor (NGF) and brain-derived neurotrophic factor, or possibly enhanced protein metabolism [53] which are thought to promote the nerve survival and regeneration. However, little is known about how acute or chronic vitamin B12 deficiency, on the one hand, and long-term supplementation, on the other, affects the formation of neurotrophic factors in the PNS. In the adult PNS, the availability of limited quantities of neurotrophic factors in a target-derived manner is essential for neuronal health. Studies suggest that vitamin B12 induces a positive balance between neurotrophic factors rather than just their expression [54]. As shown for the CNS, but most likely also true for the PNS, vitamin B12 may keep tumor necrosis factor α down and interleukin 6 and NGF upregulated, thereby promoting nerve regeneration after injury [54, 55]. Another study showed that vitamin B12 treatment delayed the onset of diabetic peripheral neuropathy via upregulation of the neural insulin growth factor-1 gene expression [29].

Two studies with rats strengthen the proposal that vitamin B12 fulfils its nerve-regenerating function by inhibiting apoptosis of damaged neurons, by affecting the methylation cycle and thereby kinases promoting neurite outgrowth and neuronal survival and by creating an environment that supports recovery [56, 57]. Dexamethasone [52] as well as cholecalciferol [58], synergistically with vitamin B12, showed significantly greater improvement of the nerve function than vitamin B12 alone. However, both effects were only demonstrated in a small cohort of animals and hitherto not proven elsewhere.

It should be also noted that positive effects of vitamin B12 on the recovery of the motor and sensory function and nerve regeneration, especially myelination, could also be shown for a new local application, namely, an electrospun nanofiber sheet incorporating methylcobalamin with local delivery [59]. While the majority of these studies examined the nerve-regenerating effect in the PNS, the results may also be transferable to the CNS [43, 60]. Wu et al. recently showed that vitamin B12 treatment in mice after traumatic brain injury rescued neurological function, stabilized microtubules, and promoted remyelination and myelin repair [43].

In summary, there is convincing evidence that vitamin B12 (cobalamin) particularly holds a nerve-regenerating role and promotes nerve cell survival, remyelination, and the maintenance of myelin sheaths, whereby improvement or even a complete cure of nerve function with physiological sensory nerve conduction velocity is achieved.

3.4. Combination of Vitamins B1, B6, and B12

Although vitamins B1, B6, and particularly B12 already show nerve-regenerating effects individually, one may assume that combining them enables synergies [61] and thereby supports nerve regeneration even more effectively. Indeed, this assumption was confirmed by Jolivalt et al. who demonstrated that the combination of vitamins B1, B6, and B12 restored sensory nerve function in rats with experimental diabetes more effectively than the individual B vitamins and did so in a dose-dependent manner [28]. Beyond that, in vitro nerve outgrowth of murine dorsal root ganglia was stronger with a combination of high-dose vitamins B1, B6, and B12 compared to combinations in which only one of the three vitamins was high dose [62]. In addition, accelerated nerve regeneration by the combination of vitamins B1, B6, and B12 was suggested from other studies [63, 64] which, however, were too small to show significant results. A recently published study investigated the effect of vitamin B therapy in the regeneration of experimental crush peripheral nerve injury to rats and appeared to contradict this finding and attributed vitamin B12 alone or in combination with B1 and B6 a stronger nerve-regenerating effect than vitamin B1 or B6 alone [65]. However, while the authors specified the doses of the individually administered vitamins (B1/B6/B12 180/180/1 mg/kg/day), they did not break it down for the combination (described as a total dose of 20 mg/kg/day). It must therefore be assumed that the combination contained less vitamins B1 and B6 than the single vitamin injections. In addition, it must be taken into consideration that the basic vitamin supply differed between the studies due to varied animal feed, making a comparison more difficult. Also, it is worth mentioning that vitamin B12 can be stored to some extent in the liver; although, it is a water-soluble vitamin. Thus, the study confirms that vitamin B12 is more important for nerve regeneration than vitamins B1 and B6 alone, but it is not sufficient to demonstrate a superiority of vitamin B12 over the combination.

Further histological evidence for the nerve-regenerating effect of the combination was provided by Becker et al. who applied cold damage to the saphenous nerve of 50 rabbits. They subsequently treated 25 rabbits with high-dose vitamins B1, B6, and B12 for 21 days while the remaining rabbits received placebo. In fact, the B vitamin combination significantly increased the number of regenerated axons, especially of myelinated fibers [66]. Moreover, a vitamin B complex containing vitamins B1, B2, B3, B5, B6, and B12 attenuated the increase in nerve and muscle nuclear density observed after injury to the femoral nerve and its target muscle in rats [67]. Another study using the same vitamin B complex demonstrated reduced local inflammation after peripheral nerve injury [68].

4. Summary and Conclusion

All of the three highlighted B vitamins may create the necessary environmental conditions for successful nerve regeneration, each of which via individual modes of action (concluded in Figure 1). Vitamin B1 essentially facilitates the energy production needed for the process and acts as a site-directed antioxidant, while vitamin B6 is vital for neurotransmitter synthesis and for inhibiting the release of neurotoxic glutamate [29, 32, 40]. Vitamin B12, on the other hand, largely promotes nerve cell survival and is strongly and directly involved in remyelination and the maintenance of myelin sheaths [41, 42, 46, 47, 56]. However, to elucidate molecular mechanisms, prove nerve-regenerating functions, and investigate neuroprotection, further experimental in vitro and in vivo studies with the individual B vitamins and the combination are needed.

Data Availability

The literature that support the conclusions of this review are within Table 1.

Conflicts of Interest

The author declares no competing interests.

Acknowledgments

The author is indebted to Dr Julia Dittmann (Hamburg, Germany) for assisting in preparing the manuscript for publication by providing writing/editing support, and the work was funded by P&G Health Germany GmbH.

References

W. A. Nix, Muscles, Nerves, and Pain, Springer, 2017.
View at: Publisher Site
B. C. Callaghan, R. S. Price, and E. L. Feldman, “Distal symmetric polyneuropathy: a review,” Journal of the American Medical Association, vol. 314, no. 20, pp. 2172–2181, 2015.
View at: Publisher Site | Google Scholar
K. A. Head, “Peripheral neuropathy: pathogenic mechanisms and alternative therapies,” Alternative Medicine Review, vol. 11, no. 4, pp. 294–329, 2006.
View at: Google Scholar
R. Hanewinckel, M. van Oijen, M. A. Ikram, and P. A. van Doorn, “The epidemiology and risk factors of chronic polyneuropathy,” European Journal of Epidemiology, vol. 31, no. 1, pp. 5–20, 2016.
View at: Publisher Site | Google Scholar
G. Landmann, “Diagnostik und Therapie der schmerzhaften Polyneuropathie,” Psychiatria et Neurologia, vol. 5, pp. 13–16, 2012.
View at: Google Scholar
R. M. G. Menorca, T. S. Fussell, and J. C. Elfar, “Nerve physiology: mechanisms of injury and recovery,” Hand Clinics, vol. 29, no. 3, pp. 317–330, 2013.
View at: Publisher Site | Google Scholar
A. D. Gaudet, P. G. Popovich, and M. S. Ramer, “Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury,” Journal of Neuroinflammation, vol. 8, no. 1, p. 110, 2011.
View at: Publisher Site | Google Scholar
K. M. Wong, E. Babetto, and B. Beirowski, “Axon degeneration: make the Schwann cell great again,” Neural Regeneration Research, vol. 12, no. 4, pp. 518–524, 2017.
View at: Publisher Site | Google Scholar
J. G. Reyes-Garcia, R. Medina-Santillan, F. J. Flores-Murrieta, N. L. Caram-Salas, and V. Granados-Soto, “Analgesic effects of B vitamins: a review,” Current Topics in Pharmacology, vol. 10, pp. 1–31, 2006.
View at: Google Scholar
G. M. Martin, “The biology of aging: 1985-2010 and beyond,” The FASEB Journal, vol. 25, no. 11, pp. 3756–3762, 2011.
View at: Publisher Site | Google Scholar
B. K. MacDonald, O. C. Cockerell, J. Sander, and S. D. Shorvon, “The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK,” Brain, vol. 123, no. 4, pp. 665–676, 2000.
View at: Publisher Site | Google Scholar
D. Ziegler, “Painful diabetic neuropathy: treatment and future aspects,” Diabetes/Metabolism Research and Reviews, vol. 24, no. S1, pp. S52–S57, 2008.
View at: Publisher Site | Google Scholar
N. Papanas, A. I. Vinik, and D. Ziegler, “Neuropathy in prediabetes: does the clock start ticking early?” Nature Reviews. Endocrinology, vol. 7, no. 11, pp. 682–690, 2011.
View at: Publisher Site | Google Scholar
S. Baltrusch, “Confocal microscope examination of the corneal nerve plexus as biomarker for systemic diseases : view from the corneal nerve plexus on diabetes mellitus disease,” Ophthalmologe, vol. 114, no. 7, pp. 592–600, 2017.
View at: Publisher Site | Google Scholar
B. Köhler, S. Allgeier, A. Bartschat et al., “In vivo imaging of the corneal nerve plexus: from single image to large scale map,” Der Ophthalmologe, vol. 114, no. 7, pp. 601–607, 2017.
View at: Publisher Site | Google Scholar
J. Stave, G. Zinser, G. Grümmer, and R. Guthoff, “Modified Heidelberg retinal tomograph HRT. Initial results of in vivo presentation of corneal structures,” Der Ophthalmologe, vol. 99, no. 4, pp. 276–280, 2002.
View at: Publisher Site | Google Scholar
A. Zhivov, S. Peschel, H.-C. Schober et al., “Diabetic foot syndrome and corneal subbasal nerve plexus changes in congolese patients with type 2 diabetes,” PLoS One, vol. 10, no. 3, article e0119842, 2015.
View at: Publisher Site | Google Scholar
A. Zhivov, K. Winter, M. Hovakimyan et al., “Imaging and quantification of subbasal nerve plexus in healthy volunteers and diabetic patients with or without retinopathy,” PLoS One, vol. 8, no. 1, article e52157, 2013.
View at: Publisher Site | Google Scholar
G. Lauria, S. T. Hsieh, O. Johansson et al., “European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Fe-deration of Neurological Societies and the Peripheral Nerve Society,” European Journal of Neurology, vol. 17, no. 7, p. 903, 2010.
View at: Publisher Site | Google Scholar
J. Leckelt, P. Guimarães, A. Kott, A. Ruggeri, O. Stachs, and S. Baltrusch, “Early detection of diabetic neuropathy by investigating CNFL and IENFD in thy1-YFP mice,” The Journal of Endocrinology, vol. 231, no. 2, pp. 147–157, 2016.
View at: Publisher Site | Google Scholar
D. Ziegler, N. Papanas, A. Zhivov et al., “Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes,” Diabetes, vol. 63, no. 7, pp. 2454–2463, 2014.
View at: Publisher Site | Google Scholar
H. Stracke, A. Lindemann, and K. Federlin, “A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy,” Experimental and Clinical Endocrinology & Diabetes, vol. 104, no. 4, pp. 311–316, 1996.
View at: Publisher Site | Google Scholar
H. U. Janka, S. Rietzel, H. Mehnert, F. Diabetes, and S. K. Mtinchen-Schwabing, “The influence of Neurobion on temperature sensibility in patients with diabetic polyneuropathy,” in Results of a Placebo-Controlled Pilot Study Der Einfluss von Neurobion Auf Die Temperatursensibilität Bei Patienten Mit Diabetischer Polyneuropathie, Pharmakologie und klinische Anwendung hochdosierter B-Vitamine, Steinkopff-Verlag, Darmstadt, 1991.
View at: Google Scholar
G. Winkler, B. Pál, E. Nagybéganyi, I. Ory, M. Porochnavec, and P. Kempler, “Effectiveness of different benfotiamine dosage regimens in the treatment of painful diabetic neuropathy,” Arzneimittel-Forschung, vol. 49, no. 3, pp. 220–224, 1999.
View at: Publisher Site | Google Scholar
A. Rizvi, A. Ahmad, and Z. Rizvi, “Efficacy of combination of vitamin B1, B6, and B12 in management of diabetic peripheral neuropathy,” Pakistan Journal of Medical & Health Sciences, vol. 7, pp. 801–804, 2013.
View at: Google Scholar
H. I. Tong, “Influence of neurotropic vitamins on the nerve conduction velocity in diabetic neuropathy,” Annals of the Academy of Medicine, Singapore, vol. 9, pp. 65–70, 1980.
View at: Google Scholar
M. Hakim, N. Kurniani, R. T. Pinzon et al., “Management of peripheral neuropathy symptoms with a fixed dose combination of high-dose vitamin B1, B6 and B12: a 12-week prospective non-interventional study in Indonesia,” Asian Journal of Medical Sciences, vol. 9, no. 1, pp. 32–40, 2018.
View at: Publisher Site | Google Scholar
C. G. Jolivalt, L. M. Mizisin, A. Nelson et al., “B vitamins alleviate indices of neuropathic pain in diabetic rats,” European Journal of Pharmacology, vol. 612, no. 1-3, pp. 41–47, 2009.
View at: Publisher Site | Google Scholar
H. Stracke, H. P. Hammes, D. Werkmann et al., “Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats,” Experimental and Clinical Endocrinology & Diabetes, vol. 109, no. 6, pp. 330–336, 2001.
View at: Publisher Site | Google Scholar
L. Jian-bo, W. Cheng-ya, C. Jia-wei, L. Xiao-lu, F. Zhen-qing, and M. Hong-tai, “The preventive efficacy of methylcobalamin on rat peripheral neuropathy influenced by diabetes via neural IGF-1 levels,” Nutritional Neuroscience, vol. 13, no. 2, pp. 79–86, 2010.
View at: Publisher Site | Google Scholar
P. R. Martin, C. K. Singleton, and S. Hiller-Sturmhofel, “The role of thiamine deficiency in alcoholic brain disease,” Alcohol Research & Health, vol. 27, no. 2, pp. 134–142, 2003.
View at: Google Scholar
G. E. Gibson and H. Zhang, “Interactions of oxidative stress with thiamine homeostasis promote neurodegeneration,” Neurochemistry International, vol. 40, no. 6, pp. 493–504, 2002.
View at: Publisher Site | Google Scholar
X.-S. Song, Z.-J. Huang, and X.-J. Song, “Thiamine suppresses thermal hyperalgesia, inhibits hyperexcitability, and lessens alterations of sodium currents in injured, dorsal root ganglion neurons in rats,” Anesthesiology, vol. 110, no. 2, pp. 387–400, 2009.
View at: Publisher Site | Google Scholar
M. Y. Geng, H. Saito, and H. Katsuki, “The effects of thiamine and oxythiamine on the survival of cultured brain neurons,” Japanese Journal of Pharmacology, vol. 68, no. 3, pp. 349–352, 1995.
View at: Publisher Site | Google Scholar
K. Takahashi and H. Nakamura, “Axonal degeneration in beriberi neuropathy,” Archives of Neurology, vol. 33, no. 12, pp. 836–841, 1976.
View at: Publisher Site | Google Scholar
T.-T. Yang and S.-J. Wang, “Pyridoxine inhibits depolarization-evoked glutamate release in nerve terminals from rat cerebral cortex: a possible neuroprotective mechanism?” The Journal of Pharmacology and Experimental Therapeutics, vol. 331, no. 1, pp. 244–254, 2009.
View at: Publisher Site | Google Scholar
K. Dakshinamurti, S. Dakshinamurti, and M. P. Czubryt, “Vitamin B6: effects of deficiency, and metabolic and therapeutic functions,” in Handbook of Famine, Starvation, and Nutrient Deprivation, V. Preedy and V. B. Patel, Eds., pp. 1–23, Springer International Publishing, Cham, 2017.
View at: Publisher Site | Google Scholar
F. G. Combs Jr., “The vitamins,” in Fundamental aspects in nutrition and health, Academic Press, 2008.
View at: Google Scholar
M. Talebi, S. Andalib, S. Bakhti, H. Ayromlou, A. Aghili, and A. Talebi, “Effect of vitamin b6 on clinical symptoms and electrodiagnostic results of patients with carpal tunnel syndrome,” Advanced Pharmaceutical Bulletin, vol. 3, no. 2, pp. 283–288, 2013.
View at: Publisher Site | Google Scholar
X.-D. Wang, S. Kashii, L. Zhao et al., “Vitamin B6 protects primate retinal neurons from ischemic injury,” Brain Research, vol. 940, no. 1-2, pp. 36–43, 2002.
View at: Publisher Site | Google Scholar
W.-C. Liao, J.-R. Chen, Y.-J. Wang, and G.-F. Tseng, “Methylcobalamin, but not methylprednisolone or pleiotrophin, accelerates the recovery of rat biceps after ulnar to musculocutaneous nerve transfer,” Neuroscience, vol. 171, no. 3, pp. 934–949, 2010.
View at: Publisher Site | Google Scholar
E. Tamaddonfard, A. A. Farshid, F. Samadi, and K. Eghdami, “Effect of vitamin B12 on functional recovery and histopathologic changes of tibial nerve-crushed rats,” Drug Research, vol. 64, no. 9, pp. 470–475, 2014.
View at: Publisher Site | Google Scholar
F. Wu, K. Xu, L. Liu et al., “Vitamin B12 enhances nerve repair and improves functional recovery after traumatic brain injury by inhibiting ER stress-induced neuron injury,” Frontiers in Pharmacology, vol. 10, p. 406, 2019.
View at: Publisher Site | Google Scholar
A. Nouri, K. Patel, J. Montejo et al., “The role of vitamin B12in the management and optimization of treatment in patients with degenerative cervical myelopathy,” Global Spine Journal, vol. 9, no. 3, pp. 331–337, 2019.
View at: Publisher Site | Google Scholar
A. Miller, M. Korem, R. Almog, and Y. Galboiz, “Vitamin B12, demyelination, remyelination and repair in multiple sclerosis,” Journal of the Neurological Sciences, vol. 233, no. 1-2, pp. 93–97, 2005.
View at: Publisher Site | Google Scholar
Y. Yuan, H. Shen, J. Yao, N. Hu, F. Ding, and X. Gu, “The protective effects of _Achyranthes bidentata_ polypeptides in an experimental model of mouse sciatic nerve crush injury,” Brain Research Bulletin, vol. 81, no. 1, pp. 25–32, 2010.
View at: Publisher Site | Google Scholar
L. Gan, G. Chen, W. du et al., “Restorative effect and mechanism of mecobalamin on sciatic nerve crush injury in mice,” Neural Regeneration Research, vol. 9, no. 22, 2014.
View at: Publisher Site | Google Scholar
B. Horasanli, A. E. Hasturk, M. Arikan et al., “Comparative evaluation of the electrophysiological, functional and ultrastructural effects of alpha lipoic acid and cyanocobalamin administration in a rat model of sciatic nerve injury,” Journal of Back and Musculoskeletal Rehabilitation, vol. 30, no. 5, pp. 967–974, 2017.
View at: Publisher Site | Google Scholar
K. Yamazaki, K. Oda, C. Endo, T. Kikuchi, and T. Wakabayashi, “Methylcobalamin (methyl-B₁₂) promotes regeneration of motor nerve terminals degenerating in anterior gracile muscle of gracile axonal dystrophy (GAD) mutant mouse,” Neuroscience Letters, vol. 170, no. 1, pp. 195–197, 1994.
View at: Publisher Site | Google Scholar
T. Watanabe, R. Kaji, N. Oka, W. Bara, and J. Kimura, “Ultra-high dose methylcobalamin promotes nerve regeneration in experimental acrylamide neuropathy,” Journal of the Neurological Sciences, vol. 122, no. 2, pp. 140–143, 1994.
View at: Publisher Site | Google Scholar
V. V. Mikhailov, V. V. Mikhailov, V. V. Onishchenko, and V. M. Avakumov, “Action of cobamamide and leukovorin on skeletal muscle reinnervation in mechanical injury to the motor nerves,” Farmakologiia i Toksikologiia, vol. 50, no. 1, pp. 34–37, 1987.
View at: Google Scholar
H. Sun, T. Yang, Q. Li et al., “Dexamethasone and vitamin B(12) synergistically promote peripheral nerve regeneration in rats by upregulating the expression of brain-derived neurotrophic factor,” Archives of Medical Science, vol. 5, no. 5, pp. 924–930, 2012.
View at: Publisher Site | Google Scholar
K. Yamatsu, Y. Yamanishi, T. Kaneko, and I. Ohkawa, “Pharmacological studies on degeneration and regeneration of peripheral nerves (II),” Folia Pharmacologica Japonica, vol. 72, no. 1-2, pp. 269–278, 1976.
View at: Publisher Site | Google Scholar
G. Scalabrino, “The multi-faceted basis of vitamin B12 (cobalamin) neurotrophism in adult central nervous system: lessons learned from its deficiency,” Progress in Neurobiology, vol. 88, no. 3, pp. 203–220, 2009.
View at: Publisher Site | Google Scholar
G. Scalabrino, F. R. Buccellato, D. Veber, and E. Mutti, “New basis of the neurotrophic action of vitamin B12,” Clinical Chemistry and Laboratory Medicine, vol. 41, no. 11, pp. 1435–1437, 2003.
View at: Publisher Site | Google Scholar
D. Wang, P. Zhang, Z. Li, and Y. Liu, “Effects of mecobalamin on Bax and Bcl-2 in neurons after peripheral nerve injury,” Chinese Journal of Industrial Hygiene and Occupational Diseases, vol. 33, pp. 841–843, 2015.
View at: Google Scholar
K. Okada, H. Tanaka, K. Temporin et al., “Methylcobalamin increases Erk1/2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model,” Experimental Neurology, vol. 222, no. 2, pp. 191–203, 2010.
View at: Publisher Site | Google Scholar
C. Albay, O. Adanir, A. Kahraman Akkalp, V. Burcu Dogan, M. Akif Gulec, and O. Beytemur, “Cyanocobalamin and cholecalciferol synergistically improve functional and histopathological nerve healing in experimental rat model,” Ideggyógyászati Szemle, vol. 73, no. 3-4, pp. 113–120, 2020.
View at: Publisher Site | Google Scholar
K. Suzuki, H. Tanaka, M. Ebara et al., “Electrospun nanofiber sheets incorporating methylcobalamin promote nerve regeneration and functional recovery in a rat sciatic nerve crush injury model,” Acta Biomaterialia, vol. 53, pp. 250–259, 2017.
View at: Publisher Site | Google Scholar
F. G. Mastronardi, H. Tsui, S. Winer et al., “Synergy between paclitaxel plus an exogenous methyl donor in the suppression of murine demyelinating diseases,” Multiple Sclerosis, vol. 13, no. 5, pp. 596–609, 2007.
View at: Publisher Site | Google Scholar
C. A. Calderon-Ospina and M. O. Nava-Mesa, “B vitamins in the nervous system: current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin,” CNS Neuroscience & Therapeutics, vol. 26, no. 1, pp. 5–13, 2020.
View at: Publisher Site | Google Scholar
A. Fujii, H. Matsumoto, and H. Yamamoto, “Effect of vitamin B complex on neurotransmission and neurite outgrowth,” General Pharmacology, vol. 27, no. 6, pp. 995–1000, 1996.
View at: Publisher Site | Google Scholar
I. Altun and E. B. Kurutas, “Vitamin B complex and vitamin B12 levels after peripheral nerve injury,” Neural Regeneration Research, vol. 11, no. 5, pp. 842–845, 2016.
View at: Publisher Site | Google Scholar
C. D. Stotzem and U. Mengs, “The effect of alpha-liponic acid, vitamin B or gangliosides on the regeneration of traumatically damaged peripheral nerves in the rat. A comparative, morphometric study,” Arzneimittel-forschung, vol. 38, no. 5, pp. 669–671, 1988.
View at: Google Scholar
S. M. AL-Saaeed, H. A. Ali, S. M. Ali, and S. A. Ali, “Vitamins B Therapy in Regeneration of Peripheral Neuropathy Associated with Lipid Profile,” Journal of Physics: Conference Series, vol. 1279, p. 012016, 2019.
View at: Publisher Site | Google Scholar
K. W. Becker, E. W. Kienecker, and P. Dick, “A contribution to the scientific assessment of degenerative and regenerative processes in peripheral nerve fibers following axonotmesis under the systemic administration of vitamins B1, B6and B12- light and electron microscopy findings in the saphenous nerve of the rabbit,” min - Minimally Invasive Neurosurgery, vol. 33, no. 4, pp. 113–121, 1990.
View at: Publisher Site | Google Scholar
P. Nedeljković, D. Zmijanjac, B. Drašković-Pavlović et al., “Vitamin B complex treatment improves motor nerve regeneration and recovery of muscle function in a rodent model of peripheral nerve injury,” Archives of Biological Sciences, vol. 69, no. 2, pp. 361–368, 2017.
View at: Publisher Site | Google Scholar
A. Ehmedah, P. Nedeljkovic, S. Dacic et al., “Vitamin B complex treatment attenuates local inflammation after peripheral nerve injury,” Molecules, vol. 24, no. 24, p. 4615, 2019.
View at: Publisher Site | Google Scholar
M. R. Romano, F. Biagioni, A. Carrizzo et al., “Effects of vitamin B12 on the corneal nerve regeneration in rats,” Experimental Eye Research, vol. 120, pp. 109–117, 2014.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2021 Simone Baltrusch. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

28254

Downloads

4300

Citations